B12 Cagrillintide Triple Therapy
  • B12 Cagrillintide Triple Therapy
  • B12 Cagrillintide Triple Therapy
  • B12 Cagrillintide Triple Therapy
  • B12 Cagrillintide Triple Therapy
B12 Cagrillintide Triple Therapy - is currently on backorder. You may still purchase now though and we'll ship as soon as more become available.

Whether you need a peptide for early research, a new chemical entity (NCE) starting clinical trials or commercial production, or analytical development and validation services, we would be happy to be your partner.

We provide comprehensive services for developing and producing glycosylated peptides, catering to quantities ranging from milligrams to kilograms. Our expertise in glycosylation enhances the bioavailability, stability, and targeting capabilities of peptides, making them highly valuable for various research and therapeutic applications.

White Label minimum quantity for FDA-registered peptides with Methyl Vitamin B12 (1000mcg API)/ml is 50,000 packs for companies interested in ANDA drug application.